BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17979577)

  • 1. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Posner K; Melvin GA; Murray DW; Gugga SS; Fisher P; Skrobala A; Cunningham C; Vitiello B; Abikoff HB; Ghuman JK; Kollins S; Wigal SB; Wigal T; McCracken JT; McGough JJ; Kastelic E; Boorady R; Davies M; Chuang SZ; Swanson JM; Riddle MA; Greenhill LL
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):547-62. PubMed ID: 17979577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Ghuman JK; Riddle MA; Vitiello B; Greenhill LL; Chuang SZ; Wigal SB; Kollins SH; Abikoff HB; McCracken JT; Kastelic E; Scharko AM; McGough JJ; Murray DW; Evans L; Swanson JM; Wigal T; Posner K; Cunningham C; Davies M; Skrobala AM
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):563-80. PubMed ID: 17979578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Murray DW; Kollins SH; Hardy KK; Abikoff HB; Swanson JM; Cunningham C; Vitiello B; Riddle MA; Davies M; Greenhill LL; McCracken JT; McGough JJ; Posner K; Skrobala AM; Wigal T; Wigal SB; Ghuman JK; Chuang SZ
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):605-20. PubMed ID: 17979581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
    Riddle MA; Yershova K; Lazzaretto D; Paykina N; Yenokyan G; Greenhill L; Abikoff H; Vitiello B; Wigal T; McCracken JT; Kollins SH; Murray DW; Wigal S; Kastelic E; McGough JJ; dosReis S; Bauzó-Rosario A; Stehli A; Posner K
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):264-278.e2. PubMed ID: 23452683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperamental and character profiles of preschool children with ODD, ADHD, and anxiety disorders.
    Melegari MG; Nanni V; Lucidi F; Russo PM; Donfrancesco R; Cloninger CR
    Compr Psychiatry; 2015 Apr; 58():94-101. PubMed ID: 25636952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Vitiello B; Abikoff HB; Chuang SZ; Kollins SH; McCracken JT; Riddle MA; Swanson JM; Wigal T; McGough JJ; Ghuman JK; Wigal SB; Skrobala AM; Davies M; Posner K; Cunningham C; Greenhill LL
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):593-604. PubMed ID: 17979580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Abikoff HB; Vitiello B; Riddle MA; Cunningham C; Greenhill LL; Swanson JM; Chuang SZ; Davies M; Kastelic E; Wigal SB; Evans L; Ghuman JK; Kollins SH; McCracken JT; McGough JJ; Murray DW; Posner K; Skrobala AM; Wigal T
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):581-92. PubMed ID: 17979579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Hardy KK; Kollins SH; Murray DW; Riddle MA; Greenhill L; Cunningham C; Abikoff HB; McCracken JT; Vitiello B; Davies M; McGough JJ; Posner K; Skrobala AM; Swanson JM; Wigal T; Wigal SB; Ghuman JK; Chuang SZ
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):621-34. PubMed ID: 17979582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood.
    van Lieshout M; Luman M; Twisk JW; van Ewijk H; Groenman AP; Thissen AJ; Faraone SV; Heslenfeld DJ; Hartman CA; Hoekstra PJ; Franke B; Buitelaar JK; Rommelse NN; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2016 Sep; 25(9):1007-17. PubMed ID: 26837866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.
    Wigal S; Chappell P; Palumbo D; Lubaczewski S; Ramaker S; Abbas R
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):104-118. PubMed ID: 31967914
    [No Abstract]   [Full Text] [Related]  

  • 19. Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.
    Lavigne JV; Cicchetti C; Gibbons RD; Binns HJ; Larsen L; DeVito C
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1393-400. PubMed ID: 11765284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do attention deficit/hyperactivity disorder and oppositional defiant disorder influence preschool unintentional injury risk?
    Garzon DL; Huang H; Todd RD
    Arch Psychiatr Nurs; 2008 Oct; 22(5):288-96. PubMed ID: 18809121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.